These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33068303)

  • 1. Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations.
    Kluwe F; Michelet R; Mueller-Schoell A; Maier C; Klopp-Schulze L; van Dyk M; Mikus G; Huisinga W; Kloft C
    Clin Pharmacol Ther; 2021 Jan; 109(1):29-36. PubMed ID: 33068303
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision dosing in clinical medicine: present and future.
    Polasek TM; Shakib S; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):743-746. PubMed ID: 30010447
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
    Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
    Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supporting Precision Dosing in Drug Labeling.
    Neely M; Onufrak N; Scheetz MH; Avedissian S; Lakota E; Deitchman AN; Gonzalez D
    Clin Pharmacol Ther; 2021 Jan; 109(1):37-41. PubMed ID: 33111328
    [No Abstract]   [Full Text] [Related]  

  • 5. Precision Dosing: The Clinical Pharmacology of Goldilocks.
    Peck RW; Shahin MH; Vinks AA
    Clin Pharmacol Ther; 2021 Jan; 109(1):11-14. PubMed ID: 33616906
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision Dosing: An Industry Perspective.
    Peck RW
    Clin Pharmacol Ther; 2021 Jan; 109(1):47-50. PubMed ID: 33107023
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting.
    Maxfield K; Milligan L; Wang L; Gonzalez D; Johnson-Williams B; Liu Q; Madabushi R; Powell R; Wang Y; Zhu H; Zineh I
    Clin Pharmacol Ther; 2021 Jan; 109(1):25-28. PubMed ID: 32663324
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologically-Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
    Rowland Yeo K; Venkatakrishnan K
    Clin Pharmacol Ther; 2021 Jan; 109(1):51-54. PubMed ID: 33220063
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and Implementation of Electronic Health Record-Integrated Model-Informed Clinical Decision Support Tools for the Precision Dosing of Drugs.
    Vinks AA; Peck RW; Neely M; Mould DR
    Clin Pharmacol Ther; 2020 Jan; 107(1):129-135. PubMed ID: 31621071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The right dose for every patient: a key step for precision medicine.
    Peck RW
    Nat Rev Drug Discov; 2016 Mar; 15(3):145-6. PubMed ID: 26669674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mathematics of drug dose individualization should be built with random-effects linear models.
    Diaz FJ; de Leon J
    Ther Drug Monit; 2013 Apr; 35(2):276-7. PubMed ID: 23503456
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models".
    Holford NH; Buclin T
    Ther Drug Monit; 2013 Dec; 35(6):873-4. PubMed ID: 24263647
    [No Abstract]   [Full Text] [Related]  

  • 13. A unified pharmacokinetic approach to individualized drug dosing.
    Begg EJ; Chin PK
    Br J Clin Pharmacol; 2012 Mar; 73(3):335-9. PubMed ID: 21851378
    [No Abstract]   [Full Text] [Related]  

  • 14. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization.
    Janković SM
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):157-162. PubMed ID: 31773426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalised dosing of medicines for children.
    Al-Metwali B; Mulla H
    J Pharm Pharmacol; 2017 May; 69(5):514-524. PubMed ID: 28266713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug-Drug Interaction Risks.
    Yang X; Pfuma Fletcher E; Huang SM; Zineh I; Madabushi R
    Clin Pharmacol Ther; 2021 Jan; 109(1):42-46. PubMed ID: 32721040
    [No Abstract]   [Full Text] [Related]  

  • 17. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of personalized drug delivery systems into digital health.
    Raijada D; Wac K; Greisen E; Rantanen J; Genina N
    Adv Drug Deliv Rev; 2021 Sep; 176():113857. PubMed ID: 34389172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Dosing: A Clinical and Public Health Imperative.
    Maxfield K; Zineh I
    JAMA; 2021 Apr; 325(15):1505-1506. PubMed ID: 33760028
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.